Guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease
ثبت نشده
چکیده
Draft agreed by Efficacy Working Party June 2007 Adopted by CHMP for release for consultation 19 July 2007 End of consultation (deadline for comments) 31 January 2008 Agreed by Efficacy Working Party July 2008 Adopted by CHMP 24 July 2008 Date for coming into effect 1 February 2009 Updated draft agreed by CNS Working Party June 2012 Adopted by CHMP 21 June 2012 Start of public consultation n/a Date for coming into effect 2 July 2012
منابع مشابه
Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)
Keywords Chronic obstructive pulmonary disease (COPD), airflow obstruction, relief of symptoms, maintenance treatment, exacerbations. 1 correction related to a change on p. 4 Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD) EMA/CHMP/700491/2012 2/17 Guideline on clinical investigation of medicinal products in the treatmen...
متن کاملGuideline on clinical investigation of medicinal products in the treatment of lipid disorders
This guideline replaces the ‘Note for guidance on clinical investigation of medicinal products in the treatment of lipid disorders (CPMP/EWP/3020/03)’. Rev. 1 and Rev. 2 were combined: Rev. 1 was regarding imaging surrogate endpoints Rev. 2 was regarding the need for outcome studies based on safety data at the time of Marketing Authorisation Application.
متن کامل